The 2 analysts offering 12-month price forecasts for Actinium Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 15.00. The median estimate represents a +467.38% increase from the last price of 2.82.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.